Therapeutic effects of thymoquinone in doxorubicin-induced hepatotoxicity via oxidative stress, inflammation and apoptosis
- PMID: 34494664
- DOI: 10.1111/ahe.12735
Therapeutic effects of thymoquinone in doxorubicin-induced hepatotoxicity via oxidative stress, inflammation and apoptosis
Abstract
Cancer is a lethal disease that is characterized by uncontrolled cell division and proliferation, and it results in death in many organisms. Doxorubicin (DOX) is a therapeutic agent used for treatment of many cancer types, but it induces serious hepatotoxicity. In this study, we aimed to determine possible hepato-therapeutic effects of thymoquinone (THQ) on DOX-induced hepatotoxicity in rats. Rats were divided into five groups (n = 8): Control, THQ (10 mg/kg/day/i.p for 14 days), Olive Oil (equal volume with THQ for 14 days), DOX (single dose, 15 mg/kg/i.p on 7th day) and DOX + THQ (10 mg/kg/day/i.p and DOX 15 mg/kg/i.p on 7th day). At the end of the experiment, liver tissues were extracted and evaluated histopathologically. eNOS, iNOS and Cas-3 immunostaining were performed to determine the expression levels. TUNEL method was used to determine apoptotic index. Furthermore, liver tissue total antioxidant status (TAS), total oxidant status (TOS), TNF-α and TGF-β levels were measured by ELISA assay. The DOX group showed histopathological deterioration compared to Control group. Moreover, apoptotic index, eNOS, iNOS and Cas-3 expressions increased in DOX group. While TAS level of the DOX group decreased, TOS level increased. TNF-α and TGF-β levels increased in DOX group. However, there was improvement in DOX + THQ group compared to DOX group. Moreover, apoptotic cell number, eNOS, iNOS and Cas-3 expressions decreased in DOX + THQ group compared to DOX group. We concluded that thymoquinone can be used as a phytotherapeutic for reducing DOX-induced liver damage.
Keywords: apoptosis; doxorubicin; inflammation; oxidative stress; thymoquinone.
© 2021 Wiley-VCH GmbH.
References
REFERENCES
-
- Al Aboud, D., Baty, R. S., Alsharif, K. F., Hassan, K. E., Zhery, A. S., Habotta, O. A., Elmahallawy, E. K., Amin, H. K., Abdel Moneim, A. E., & Kassab, R. B. (2021). Protective efficacy of thymoquinone or ebselen separately against arsenic-induced hepatotoxicity in rat. Environmental Science and Pollution Research International, 28(5), 6195-6206. https://doi.org/10.1007/s11356-020-10955-1
-
- Al-Dalaen S. M. (2014). Review Article: Oxidative Stress Versus Antioxidants. American Journal of Bioscience and Bioengineering, 2(5), 60. http://dx.doi.org/10.11648/j.bio.20140205.11
-
- Bilgic, S., & Ozgocmen, M. (2019). The protective effect of misoprostol against doxorubicin induced liver injury. Biotechnic and Histochemistry, 94(8), 583-591. https://doi.org/10.1080/10520295.2019.1605457
-
- Cainelli, F., & Vallone, A. (2009). Safety and efficacy of pegylated liposomal doxorubicin in HIV-associated Kaposi's sarcoma. Biologics, 3, 385-390. https://doi.org/10.2147/btt.2009.3455
-
- Cha, D. I., Song, K. D., Ha, S. Y., Hong, J. Y., Hwang, J. A., & Ko, S. E. (2021). Long-term follow-up of oxaliplatin-induced liver damage in patients with colorectal cancer. British Journal of Radiology, 94(1123), 20210352. https://doi.org/10.1259/bjr.20210352
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical